Register for email alerts and news feeds:
This journal | BMJ Group
rss
Journal of Medical Genetics 2008;45:603-606; doi:10.1136/jmg.2008.059568
Copyright © 2008 by the BMJ Publishing Group Ltd.

MUTATION REPORT

Identification of a novel TP53 germline mutation E285V in a rare case of paediatric adrenocortical carcinoma and choroid plexus carcinoma

A Russell-Swetek1, A N West2, J E Mintern3, J Jenkins4, C Rodriguez-Galindo5, R Ribeiro5,6, G P Zambetti1

1 Department of Biochemistry, St Jude Children’s Research Hospital, Memphis, Tennessee, USA
2 Interdisciplinary Sciences, University of Tennessee Health Science Center, Memphis, Tennessee, USA
3 Division of Oncology and Neuro-Oncology, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
4 Department of Pathology, St Jude Children’s Research Hospital, Memphis, Tennessee, USA
5 Department of Oncology, St Jude Children’s Research Hospital, Memphis, Tennessee, USA
6 International Outreach Program, St Jude Children’s Research Hospital, Memphis, Tennessee, USA

Correspondence to:
Dr G P Zambetti, Department of Biochemistry, St Jude Children’s Research Hospital, 332 N Lauderdale, Memphis TN 38105, USA; gerard.zambetti{at}stjude.org

Paediatric choroid plexus carcinomas (CPC) and adrenocortical carcinomas (ACC) are exceedingly rare tumours, each occurring at an annual rate of 0.3 cases per million children or less. Although both tumour types are associated with Li–Fraumeni syndrome (LFS), the penetrance of germline TP53 mutations in CPC remains to be established. We report here a young boy without a family history of cancer who presented with CPC and subsequently ACC. Genetic testing revealed a novel de novo germline TP53 mutation (E285V). Neither tumour underwent loss of heterozygosity. Consistent with this observation, functional analyses demonstrated that E285V acts as a dominant negative mutant that is defective in regulating target gene expression, growth suppression and apoptosis. These results further strengthen the association between germline TP53 mutations and childhood CPC, even when occurring in the absence of familial tumour susceptibility.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Genetics jobs

Genetics jobs